Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age

To describe the pharmacokinetics, safety, and efficacy of etravirine (ETR) in HIV-infected children 1 to less than 6 years of age. DESIGN: Phase I/II, open-label, multicenter, dose-finding study. METHODS: Antiretroviral therapy (ART)-experienced children in two age cohorts (I: 2 to <6 years; II:...

Descripción completa

Detalles Bibliográficos
Autores principales: MacBrayne, Christine E., Rutstein, Richard M., Wiznia, Andrew A., Graham, Bobbie, Alvero, Carmelita G., Fairlie, Lee, Lypen, Kathryn, George, Kathleen H., Townley, Ellen, Moye, Jack, Costello, Diane G., Reding, Christina A., Barroso Hofer, Cristina, Crauwels, Herta M., Woot de Trixhe, Xavier, Tambuyzer, Lotke, Vanveggel, Simon, Opsomer, Magda, Kiser, Jennifer J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270511/
https://www.ncbi.nlm.nih.gov/pubmed/33831904
http://dx.doi.org/10.1097/QAD.0000000000002902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270511/
https://www.ncbi.nlm.nih.gov/pubmed/33831904
http://dx.doi.org/10.1097/QAD.0000000000002902

Ejemplares similares